N/A
Completed N=60
Social Media HIV Prevention Intervention for High Risk Rural Women
Source: ClinicalTrials.gov NCT03456453 ↗Enrolled (actual)
60
Serious AEs
4.0%
Results posted
May 2023
Primary outcomePrimary: Facebook Enrollment — 15; 15 Participants
Summary
The overall aim of this R34 application is to adapt and feasibility test an evidence-based HIV prevention education for high-risk, underserved rural women in Appalachia. This study has potential to make a significant contribution to science by advancing knowledge on the use of social media to increase access to prevention interventions to reduce high-risk substance use and related health disparities among rural women during a time of emerging and significant public health risk in Appalachia. Successfully accomplishing study aims will respond to a critical and unmet need to increase access to prevention interventions using social media, as well as advance knowledge about the high-risk drug use behaviors among vulnerable populations.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Facebook Enrollment |
15; 15 | — |
| SECONDARY Number of Participants With Use of Injected Drugs |
8; 6 | — |
Eligibility Criteria
Inclusion Criteria
- NM-ASSIST indicators of high-risk drug use during the 6 months before jail (including injection);
- engagement in at least one sexual risk behavior in the past 3 months;
- no evidence of cognitive impairment (GAIN, Dennis, 1998),
- no evidence of active psychosis (currently experiencing hallucinations),
- no self-reported current symptoms of physical withdrawal from a recent episode of drug use;
- self-reported HIV negative status;
- projected jail release date within 3 months;
- active Facebook user prior to entering jail (defined as having a Facebook account that was checked at least once a week); and
- reside in a rural, Appalachian county prior to incarceration.
Exclusion Criteria
- Not incarcerated and screened eligible based on above mentioned criteria
Data sourced from ClinicalTrials.gov (NCT03456453). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.